Alcon Aktie
81,24CHF | 0,68CHF | 0,84% |
WKN DE: A2PDXE / ISIN: CH0432492467
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 22 142 | 23 655 | 24 389 | 25 178 | 25 315 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,34 | 0,27 | 0,31 | 0,33 | 0,34 |
Bilanz (in Mio. CHF) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 4 102 | 4 408 | 4 907 | 4 805 | 4 753 |
Summe Anlagevermögen | 22 678 | 19 989 | 20 604 | 22 220 | 20 172 |
Summe Aktiva | 26 780 | 24 397 | 25 511 | 27 024 | 24 925 |
Bilanz (in Mio. CHF) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 8 088 | 7 759 | 7 966 | 8 819 | 7 566 |
Summe Eigenkapital | 18 692 | 16 638 | 17 545 | 18 205 | 17 358 |
Summe Passiva | 26 780 | 24 397 | 25 511 | 27 024 | 24 925 |
Adresse
Royce Bedward, 1214 Geneva | |
Telefon | +41 (817) 293-04-50 |
Fax | +41 (817) 916-26-52 |
Internet | http://www.alcon.com |
Management
Arthur Cummings
Independent Director |
Bono Raquel Cruz
Director |
D. Keith Grossman
Vice Chairman |
Daniel E. Cravens
Investor Relations Contact |
David J. Endicott
Chief Executive Officer & Director |
Dieter Spälti
Independent Director |
Edward McGough
Head-Global Manufacturing & Technical Operations |
F. Michael Ball
Chairman |
Franck Leveiller
SVP, Head-Global Research & Development |
Heather Attra
Senior Vice President-Quality & Regulatory Affairs |
Ian Bell
President-Global Business & Innovation |
Ines Pöschel
Independent Director |
Joe Rappon
VP-Pharmaceutical Research & Development |
Karen J. May
Independent Director |
Kim Martin
Chief Human Resources Officer & Senior VP |
Laurent Attias
Head-Strategy & Business Development |
Leon Sergio Duplan Fraustro
President-North America Division |
Lynn Dorsey Bleil
Independent Director |
Rajkumar Narayanan
President-International |
Royce R. Bedward
Secretary, Senior Vice President & General Counsel |
Scott Maw
Independent Director |
Sue-Jean Lin
SVP, Chief Information & Transformation Officer |
Thomas Heinrich Glanzmann
Independent Director |
Timothy C. Stonesifer
Chief Financial Officer |